Operating
Other Current Liabilities
Agilent Technologies Other Current Liabilities remained flat by 0.0% to $2.75M in Q3 2025 compared to the prior quarter. Year-over-year, this metric grew by 22.2%, from $2.25M to $2.75M. Over 4 years (FY 2021 to FY 2025), Other Current Liabilities shows a downward trend with a -20.1% CAGR.
Analysis
StatementCash Flow Statement
SectionOperating
CategoryLiquidity
SignalContext dependent
VolatilityModerate
First reportedQ1 2021
Last reportedQ4 2025Dec 22, 2025
How to read this metric
An increase acts as a source of cash, while a decrease acts as a use of cash as these obligations are settled.
Detailed definition
This tracks the change in miscellaneous current liabilities, such as accrued wages, interest, or other short-term obliga...
Peer comparison
Varies by company based on the nature of their specific accrual categories.
Metric ID:
operating_increase_decrease_in_other_accounts_payable_an_5b9da7Historical Data
5 years
| FY'21 | FY'22 | FY'23 | FY'24 | FY'25 | |
|---|---|---|---|---|---|
| Value | $27.00M | $26.00M | $4.00M | $9.00M | $11.00M |
| YoY Change | — | -3.7% | -84.6% | +125.0% | +22.2% |
Range$4.00M – $27.00M
CAGR-20.1%
Avg YoY Growth+14.7%
Median YoY Growth+9.3%
Current Streak2 years growth
Other Current Liabilities at Other Companies
Frequently Asked Questions
- What is Agilent Technologies's other current liabilities?
- Agilent Technologies (A) reported other current liabilities of $2.75M in Q3 2025.
- How has Agilent Technologies's other current liabilities changed year-over-year?
- Agilent Technologies's other current liabilities increased by 22.2% year-over-year, from $2.25M to $2.75M.
- What is the long-term trend for Agilent Technologies's other current liabilities?
- Over 4 years (2021 to 2025), Agilent Technologies's other current liabilities has grown at a -20.1% compound annual growth rate (CAGR), from $27.00M to $11.00M.
- What does other current liabilities mean?
- The change in cash impact from miscellaneous short-term obligations other than trade payables.